Advertisement

Topics

Oxford Communications, Ltd. Company Profile

10:29 EDT 21st September 2017 | BioPortfolio


News Articles [582 Associated News Articles listed on BioPortfolio]

#jobs #lifescience Paramount Recruitment: Medical Writer – Healthcare Communications – Oxford

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Paramount Recruitment: Medical Writer – Healthcare Communications ̵...

New light on the secret life of badgers

(University of Oxford) Badgers are more sociable than often thought, with implications for how they transmit disease, new Oxford University research reveals. Using security tracking technology more co...

#jobs #lifescience Immunocore: Early Diagnostic Senior Scientist – Oxford

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Immunocore: Early Diagnostic Senior Scientist – Oxford . Competitive sa...

Oxford Synbio Startup with Eyes on Therapeutics gets hold of CRISPR

Synbio startup Oxford Genetics has licensed CRISPR from Emmanuelle Charpentier’s company, ERS Genomics, to boost its platform. Synthetic biology has so far remained on the fringe of biotech, but...

Oxford Genetics Secures ??7.5 Million Investment

21st August 2017, Oxford Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, has announced a 7.5 million investment into it...

Oxford researchers develop new scan to predict stroke

Researchers at the University of Oxford, supported by the NIHR Oxford Biomedical Research Centre, have developed a new type of MRI scan to predict the risk of having a stroke. The non-invasive techniq...

Event showcases Oxford’s role in cutting-edge medical technology

Some of the latest breakthroughs in precision medicine and digital health that are transforming patient care – many of them developed in Oxford – have been in the spotlight at an event held on...

Oxford Biomedica Announces Major Supply Agreement

NewsThis amount includes a $10 million upfront payment, various performance incentives and bioprocessing and development services.

Drugs and Medications [0 Results]

None

PubMed Articles [634 Associated PubMed Articles listed on BioPortfolio]

Changes in prescribing and healthcare resource utilization after FDA Drug Safety Communications involving zolpidem-containing medications.

Products containing the sedative/hypnotic zolpidem were subject to Drug Safety Communications (DSCs) in January and May 2013 describing the risk of next-morning impairment and recommending lower start...

Communications.

The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy.

The Oxford Classification for Immunoglobulin A nephropathy (IgAN) identifies pathological variables that may predict the decline of renal function. This study aimed to evaluate the Oxford Classificati...

XXXIX Reunion Anual de la Sociedad Andaluza de Neurologia. Communications (II).

XVI Reunion de la Sociedad Castellano-Manchega de Neurologia. Communications.

Clinical Trials [79 Associated Clinical Trials listed on BioPortfolio]

Oxford Partial Knee Replacement. A Randomized Clinical Trial of Three Implant Types

The purpose of this scientific study is to clarify whether there is a relationship between the appearance of radiolucent lines in bone-cement interphase of the tibial component of the diff...

A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System

The purpose of this study is to collect information on complications and survivorship of patients implanted with the Oxford™ Meniscal Unicompartmental Knee System at multiple sites in th...

Oxford® Partial Knee Kinematics Gait Analysis Study

The objective of this study is to compare the effect on gait of unicompartmental knee arthroplasty (UKA), using the Oxford® Partial Knee, versus total knee arthroplasty (TKA), using the V...

Outcome Analysis of the Oxford Partial Knee Arthroplasty

Prospectively monitor the patients receiving the Oxford Partial knee arthroplasty

A Clinical Investigation of the Oxford® Partial Knee System

The purpose of this prospective data collection is to document the performance and clinical outcomes of the Oxford® Partial Knee System.

Companies [506 Associated Companies listed on BioPortfolio]

Oxford Communications, Ltd.

Oxford Communications

Oxford Resource Partners, LP

Oxford Resource Partners, LP is a low cost producer of high value steam coal in Northern Appalachia and the Illinois Basin. Oxford markets its coal primarily to large electric utilities with coal-fir...

Oxford Healthcare Technology

Oxford Healthcare Technology is a staffing firm that leverages their recruiting expertise to deliver experienced healthcare professionals and project teams for consulting engageme...

Oxford Lasers, Inc.

Since 1977, Oxford Lasers has been supplying laser solutions to science and industry. Oxford Lasers was founded in 1977 by physicists from Oxford University whose research had been directed towards th...

More Information about "Oxford Communications, Ltd." on BioPortfolio

We have published hundreds of Oxford Communications, Ltd. news stories on BioPortfolio along with dozens of Oxford Communications, Ltd. Clinical Trials and PubMed Articles about Oxford Communications, Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oxford Communications, Ltd. Companies in our database. You can also find out about relevant Oxford Communications, Ltd. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record